Pneuma Respiratory, Inc., founded to revolutionize inhaled therapeutics, is a US-based medical equipment manufacturer. The company's core mission is to advance digital lung therapies, focusing on therapeutic treatments for smoking-related lung conditions and other respiratory disorders. Their innovative platform aims to enhance the delivery of inhaled drugs, offering solutions for smoking cessation, non-small cell lung cancer, and other lung diseases.
Notable figures affiliated with Pneuma Respiratory include experts in med-tech and pharmaceuticals who drive the company's vision forward. The company has garnered attention from key investors in the healthcare sector, contributing to its rapid growth and development. Pneuma Respiratory's impact is evident in its pioneering approach to digital inhaled therapeutics, positioning it as a leader in the treatment of lung conditions.
